InSysBio students defended master’s thesis

NEWS
Education
July 22, 2019

July 22, 2019

Two students from Lomonosov Moscow State University (MSU) did their master’s dissertations in InSysBio and successfully graduated from MSU in July. Stepan Lerner defended master thesis entitled “Mathematical model of the beta amyloid influence on synaptic transmission” supervised by Tatiana Karelina, Expert Modeler, lead Alzheimer’s Disease Modeling Consortium. Dmitry Shchelokov defended master thesis entitled “Physiologically based pharmacokinetic modeling of anti-PD-1 therapeutic antibodies” supervised by Oleg Demin Jr, Head of Business Development of InSysBio and Expert Modeler.

About InSysBio

InSysBio is a Quantitative Systems Pharmacology (QSP) company located in Moscow, Russia (INSYSBIO LLC) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative approach has already become a part of the drug development process implemented by our strategic partners: nowadays there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry. The company has published multiple scientific studies in various therapeutic areas. InSysBio team is developing software and tools for QSP and continuously improves methods for biological modeling. For more information about InSysBio, its solutions and services, visit insysbio.com.

November 2021
MoTuWeThFrSaSu
1
2
3
4
5
6
7
8
9
10
1. 10 Nov 2021 20:48 InSysBio to take part in ACoP12 InSysBio announces its participation in Twelfth American Conference on Pharmacometrics (ACoP12) which is to be held in virtual format this year from November 8-12, 2021. The theme of ACoP12 is “Charting the Course for Our Future”. InSysBio team is going to present the update at its Virtual Booth and 12 posters in frames of the Conference
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
1. 30 Nov 2021 15:17 The new website represents InSysBio’s diverse expertise and corporate philosophy InSysBio announces the launch of its new website. The aim of redesign was to fully represent all InSysBio’s diversified experience and to reflect the company’s current trend. The new website is more structured, user-friendly and provides more opportunities for feedback.
     
Upcoming Events
18.10
InSysBio to participate in ACoP 2025
Tags
Latest News
19.08
InSysBio to publish the new article "Revolutionizing drug discovery: Integrating artificial intelligence with quantitative systems pharmacology"
05.08
InSysBio to launch Immune Response Template Open for QSP modeling
25.06
InSysBio to announce extension of collaboration with discoveric bio alpha
18.06
InSysBio to publish the new article in CPT: Pharmacometrics & Systems Pharmacology
03.06
InSysBio to present Integration of Cytocon DB and fIVE DB with Heta for QSP modeling